812. Immune Checkpoint Inhibitors for Treatment of Cancer
Session: Symposium: Friendly Fire—Immunotherapies and Infectious Diseases
Thursday, October 27, 2016: 2:30 PM
Room: Theater A & B
Mark Awad, MD, PhD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Disclosures:

M. Awad, None

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.